BIOASTER has been selected as a TRI (Technology Research Institute). Its main activity is research and development in the areas of microbiology and infectious disease, with strong backing from public-private partnerships.
In accordance with the principles governing the operation of TRIs, BIOASTER's activities receive balanced co-funding:
- Mainly private sources: collaboration agreements with industrial partners, European collaborative projects, grants from local authorities, etc.
||A multiyear financing agreement was signed with the National Research Agencyon July 5, 2012. This agreement specifies BIOASTER’s goals through 2020.|
The launch of BIOASTER was made possible by the donations and grants of its founders.
As a Fondation de Coopération Scientifique (Foundation for Scientific Cooperation), BIOASTER is a not-for-profit organization but has a long-term goal of self-financing through future income from the use of its research.
That status allows Bioaster to receive donations; BIOASTER is open to any potential partners who wish to co-fund research projects, independently or through a partnership.
For more information about donations: firstname.lastname@example.org
The founding members are committed to financing the BIOASTER FSC with up to €7.3M.
During the first three years:
• Launch of 40 R&D projects
• €90M in estimated combined financing by private partners, local authorities, and the government
Objective to a nine-year horizon:
• Overall budget of €585M, including €180M provided by the government as part of the Investments for the Future program
• Several hundred researchers
• 30 to 40,000 sq. m. of space, including 5000 sq. m. immediately dedicated to Bioaster on the Charles Mérieux-Lyon University campus in Lyon/Gerland and Institut Pasteur in Paris.